The Massachusetts Board of Allied Health Professions recently issued regulations requiring all individual licensees to complete continuing competence activities (i.e., continuing education) before renewal. Please visit the board’s website to find the prorated schedule of continuing competency requirements. All renewals due in August 2024, or later, must complete the mandatory ethics, laws, and regulations continuing competence activities.
If you are an athletic trainer licensed in Massachusetts, please select BOC from the Associations menu. For more information, visit A Guide to Using the PhysicalTherapy.com Library for PTs/PTAs and ATs. PhysicalTherapy.com is currently developing an ethics course tailored toward athletic trainers that will be available soon.
1https://www.physicaltherapy.com/pt-ceus/course/glp-1-weight-loss-medications-4952GLP-1 Weight Loss Medications: What Healthcare Providers Should Know!The GLP-1 medications have become a popular treatment for individuals with type II diabetes or obesity. Healthcare providers must understand these medications, including the benefits, adverse effects, and contraindications. For some individuals, these medications can have consequences such as loss of lean mass loss, which can affect their function, health, and longevity. This presentation will provide an evidence-based update on this topic.auditory, textual, visual129USDSubscriptionUnlimited COURSE Access for $129/yearOnlineOnlyPhysicalTherapy.comwww.physicaltherapy.comGLP-1 Weight Loss Medications: What Healthcare Providers Should Know!The GLP-1 medications have become a popular treatment for individuals with type II diabetes or obesity. Healthcare providers must understand these medications, including the benefits, adverse effects, and contraindications. For some individuals, these medications can have consequences such as loss of lean mass loss, which can affect their function, health, and longevity. This presentation will provide an evidence-based update on this topic.4952OnlinePT120M
The GLP-1 medications have become a popular treatment for individuals with type II diabetes or obesity. Healthcare providers must understand these medications, including the benefits, adverse effects, and contraindications. For some individuals, these medications can have consequences such as loss of lean mass loss, which can affect their function, health, and longevity. This presentation will provide an evidence-based update on this topic.
